Loezar, CristóbalCristóbalLoezarMadrid, EvaEvaMadridPérez, JavierJavierPérezManuel Jose Barros MongeGerard UrrútiaMarta Roqué i FigulsJavier BracchiglioneManuel Vargas PeiranoXavier Bonfill2025-08-252025-08-252018-07-1310.1002/14651858.cd0130752-s2.0-85049857941https://cris-uv-2.scimago.es/handle/123456789/3209This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of taxanes as part of a combined or single-agent therapy versus other agents or best supportive care as first- or second-line treatment for advanced non-small cell lung cancer (NSCLC). A secondary objective is to assess different modes or schemes of administration of taxanes in patients with this disease.enacceso restringidoMedicinePharmacologyreview